Qingdao Baiyang Pharmaceutical Co., Ltd. announced the full repayment of 54,992.29 million yuan of idle raised funds used for temporary working capital. The funds were repaid to the special account for raised funds before August 10, 2026, within the approved 12-month period. The company has notified its sponsor.
Summary generated by AI · Always verify with source document
Stock Code: 301015
Bond Code: 123194
Stock Abbreviation: Baiyang Pharmaceutical
Bond Abbreviation: Baiyang Convertible Bond
Announcement No.: 2026-061
Qingdao Baiyang Pharmaceutical Co., Ltd.
Announcement on the Repayment of Raised Funds Temporarily Supplementing Working Capital
The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.